Nasopharyngeal cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1: Healthy group: Individuals aged 18-80 years old who experience physical examination with normal blood routine, urine routine, liver function biochemical indexes, renal function biochemical indexes, and cardiac enzyme spectrum biochemical indexes. 2: Nasopharyngeal carcinoma group: 18-80 years old, pathologically confirmed, untreated patients. 3: Benign nasopharyngeal disease group: patients with benign nasopharyngeal diseases who have symptoms such as epistaxis, nasal discharge with blood, nasal congestion, rhinitis, sinusitis, nasopharyngeal mass, tinnitus, deafness, headache, etc, 18-80 years old, with clear diagnosis results.
Exclusion criteria
Exclusion criteria: 1: Healthy group: use immune-related drugs within 6 months; have autoimmune diseases; have tumors or abnormal tumor markers; abnormal electrolyte biochemical indicators. 2: Nasopharyngeal carcinoma group: patients with autoimmune diseases or more than two types of tumors. 3: Benign nasopharyngeal disease group: patients with nasopharyngeal carcinoma who have been diagnosed and treated in the past; patients taking immunosuppressants; patients whose source is not traceable or whose basic information is incomplete; diagnostic information is incomplete.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Immune-related indicators ;Objective response rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Epstein-Barr virus-related indicators ;Disease-free survival ;Overall survival ; | — |
Countries
China
Contacts
Department of Clinical Laboratory, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College